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SUMMARY
In 54 patients presenting for electroconvulsive therapy, the concentration of
serum potassium was measured before and after the induced convulsion
modified with a standard anaesthetic technique of methohexitone and
suxamethonium. It was found that there was a statistically significant rise in
serum potassium, but that the duration ofconvulsion had no significant effect on
that rise in serum potassium. In a further 11 patients, methohexitone alone was
administered without ECT, and it was found that serum potassium fell.
Methohexitone, suxamethonium and ECT in combination cause a rise in serum
potassium which is not clinically important unless pre-induction level is
abnormally high, and prolonged convulsion does not exaggerate this rise.
INTRODUCTION
Electroconvulsive therapy (ECT) has been used in the management of various
psychiatric disorders for over 50 years. More recently, the tonic/clonic
convulsion induced by this therapy has been modified by the use of
suxamethonium. It is well documented that suxamethonium causes increases in
serum potassium,' and at first sight it might be expected that the combination of
suxamethonium fasciculation and the modified tonic/clonic convulsion induced
by ECT would cause a more exaggerated rise in the level ofserum potassium than
that produced by suxamethonium alone. However, several studies have shown
that the rise produced by the combination is rarely of clinical significance.2 3,4,5
These authors did not examine the possible link between duration of fit and the
subsequent elevation in serum potassium.
The aim of this study was to examine the relationship between serum potassium
changes and the duration of the tonic/clonic convulsion using a standard
anaesthetic technique.
METHODS
Fifty-four unpremedicated, ASA grade I and 11 patients, presenting for elective
ECT were studied. Research Ethical Committee approval was obtained, and
patients gave informed verbal consent. An indwelling 21 gauge needle was
inserted on the dorsum of both hands (one for the administration of anaesthetic
drugs, one for blood sampling). A sample of blood was obtained for basal
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serum potassium measurement, and then induction was achieved with 1mg/kg
methohexitone, followed by 0*5mg/kg suxamethonium. The lungs were
manually inflated with oxygen, and ECT given 15 to 20 seconds after suxa-
methonium fasciculation. A further sample of blood for potassium was withdrawn
120 seconds after drug administration without venous occlusion. The duration of
the tonic/clonic convulsion was timed. In a further 11 patients, methohexitone
1mg/kg alone was administered (ie no suxamethonium and no ECT) as part of
their normal therapy in this hospital. Blood samples were obtained before and
120 seconds after methohexitone administration.
Those samples not immediately analysed were stored at 40C for a maximum of
four hours. Potassium concentrations were determined using a Corning 480
flame photometer after visually ensuring the absence of haemolysis by an
independent laboratory technician (those showing haemolysis were excluded
from the study). Based on precision of routine quality control, changes in excess
of 0-1 mmol/1 were considered significant. Results were analysed statistically
using the Wilcoxon signed rank test and correlation coefficient (Table).
TABLE
Serum potassium (mmol/I) before and after suxamethonium/ECT, and before
and after methohexitone (medians and ranges)
Serum potassium (mmol/l) Duration of
Before After Change fit (secs)
Suxamethonium
and ECT
Median 4-1 4.4 +0.2 20
Range 3-8-4-9 4-0-5-2 -0-5- +0-4 0-55
Methohexitone
Median 4.4 3-8 -0-2
Range 3-7-5-6 3.5-4-4 -18- +0-4
RESULTS
The changes in serum potassium associated with suxamethonium and ECT
therapy are shown in the Table. There was a statistically significant rise in serum
potassium following suxamethonium/ECT (p <0u 001) which affected 41 out
of the 54 patients, nine showing no alteration. There was a weakly negative
correlation between serum potassium change and duration of convulsion
(r = -0*36, p< 0*01).The alterationsin serum potassium in the methohexitone
only group are given. Serum potassium rose in two patients, fell in seven and was
unchanged in two (p < 0 05, Wilcoxon signed rank test).
DISCUSSION
The results ofthis study confirm that small but statistically significant increases in
serum potassium occur after ECT modified by suxamethonium in the majority of
patients. The maximum rise was 0 4 mmol/l, and is unlikely to be of clinical
significance unless the pre-anaesthetic level is above the upper normal value.
Wide variation in the duration of modified convulsion was observed, ranging
from 0 to 55 seconds, with only a weakly negative correlation to subsequent
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alteration in serum potassium. This tends to support the view of Bali2 that the
convulsion pumps the muscle venous blood which is rich in potassium following
suxamethonium fasciculation into the general circulation, without causing hyper-
kalaemia by itself. Pilditch and Baker3 have also shown that the grade of
convulsion, using anarbitrary grading system, produced nosignificant differences
in serum potassium.
Methohexitone was used as the induction agent in this study as the majority of
patients attended as day patients. Eleven patients received methohexitone alone,
with no ECT. Potassium levels in these patients fell, demonstrating the protective
effect against large rises in serum potassium noted by other authors, which
applies also to thiopentone.6
This study confirms that small rises in serum potassium follow the use of
methohexitone and suxamethonium for ECT. There does not appear to be any
consistent relationship betweentheduration oftheconvulsion and thesubsequent
change in serum potassium in normal patients. In addition, methohexitone
appears toattenuatethe riseinserum K + associated with themodified convulsion
of ECT.
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